Quidel Corporation (QDEL) - Total Assets
Based on the latest financial reports, Quidel Corporation (QDEL) holds total assets worth $5.77 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See QDEL book value for net asset value and shareholders' equity analysis.
Quidel Corporation - Total Assets Trend (1985–2025)
This chart illustrates how Quidel Corporation's total assets have evolved over time, based on quarterly financial data.
Quidel Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
Quidel Corporation's total assets of $5.77 Billion consist of 25.1% current assets and 74.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.9% |
| Accounts Receivable | $417.00 Million | 7.2% |
| Inventory | $577.60 Million | 10.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.56 Billion | 44.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1985–2025)
This chart illustrates how Quidel Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Quidel Corporation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Quidel Corporation's current assets represent 25.1% of total assets in 2025, a decrease from 92.6% in 1985.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, down from 77.7% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is intangible assets at 44.4% of total assets.
Quidel Corporation Competitors by Total Assets
Key competitors of Quidel Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Quidel Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.22 | 3.50 |
| Quick Ratio | 0.90 | 0.69 | 3.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $481.20 Million | $220.10 Million | $915.78 Million |
Quidel Corporation - Advanced Valuation Insights
This section examines the relationship between Quidel Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.74 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -10.2% |
| Total Assets | $5.77 Billion |
| Market Capitalization | $860.55 Million USD |
Valuation Analysis
Below Book Valuation: The market values Quidel Corporation's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Quidel Corporation's assets decreased by 10.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Quidel Corporation (1985–2025)
The table below shows the annual total assets of Quidel Corporation from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $5.77 Billion | -10.19% |
| 2024-12-31 | $6.42 Billion | -24.99% |
| 2023-12-31 | $8.56 Billion | -3.31% |
| 2022-12-31 | $8.86 Billion | +264.38% |
| 2021-12-31 | $2.43 Billion | +29.89% |
| 2020-12-31 | $1.87 Billion | +105.43% |
| 2019-12-31 | $910.87 Million | +12.96% |
| 2018-12-31 | $806.37 Million | -13.78% |
| 2017-12-31 | $935.25 Million | +140.89% |
| 2016-12-31 | $388.25 Million | -4.49% |
| 2015-12-31 | $406.50 Million | -9.14% |
| 2014-12-31 | $447.41 Million | +64.80% |
| 2013-12-31 | $271.49 Million | +12.14% |
| 2012-12-31 | $242.10 Million | -13.19% |
| 2011-12-31 | $278.89 Million | +29.96% |
| 2010-12-31 | $214.59 Million | +29.00% |
| 2009-12-31 | $166.34 Million | +16.48% |
| 2008-12-31 | $142.81 Million | +6.70% |
| 2007-12-31 | $133.84 Million | +5.34% |
| 2006-12-31 | $127.05 Million | +11.59% |
| 2005-12-31 | $113.85 Million | +1.03% |
| 2004-12-31 | $112.69 Million | -3.89% |
| 2003-12-31 | $117.25 Million | +41.96% |
| 2002-12-31 | $82.59 Million | +0.24% |
| 2001-12-31 | $82.39 Million | +0.44% |
| 2000-12-31 | $82.03 Million | +20.64% |
| 1999-12-31 | $68.00 Million | +29.28% |
| 1998-12-31 | $52.60 Million | +10.04% |
| 1997-12-31 | $47.80 Million | +13.00% |
| 1996-12-31 | $42.30 Million | +27.03% |
| 1995-12-31 | $33.30 Million | -3.48% |
| 1994-12-31 | $34.50 Million | +4.86% |
| 1993-12-31 | $32.90 Million | +55.19% |
| 1992-12-31 | $21.20 Million | +10.99% |
| 1991-12-31 | $19.10 Million | -15.49% |
| 1990-12-31 | $22.60 Million | +276.67% |
| 1989-12-31 | $6.00 Million | +3.45% |
| 1988-12-31 | $5.80 Million | +1.75% |
| 1987-12-31 | $5.70 Million | -60.14% |
| 1986-12-31 | $14.30 Million | -18.29% |
| 1985-12-31 | $17.50 Million | -- |
About Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more